Monitoring and Predicting Chemotherapy Response Using DOSI

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

October 6, 2014

Conditions
Breast Cancer
Interventions
PROCEDURE

DOSI

Bedside DOSI images of the tissue concentrations of deoxy-hemoglobin (ctHHb), oxy-hemoglobin (ctHbO2), water (ctH2O), lipid, tissue oxygen saturation (StO2), and TOI (ctHHb x tH2O/lipid) were acquired on both breasts up to four times during neoadjuvant chemotherapy (NAC) treatment.

Trial Locations (2)

92617

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Irvine

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

American College of Radiology Imaging Network

NETWORK

NCT01217385 - Monitoring and Predicting Chemotherapy Response Using DOSI | Biotech Hunter | Biotech Hunter